Profile | GDS4284 / 233550_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 202.134 | 50 |
GSM687648 | Patient 402 control | 228.479 | 51 |
GSM687653 | Patient 403 control | 246.11 | 53 |
GSM687658 | Patient 404 control | 243.829 | 52 |
GSM687663 | Patient 411 control | 219.203 | 49 |
GSM687668 | Patient 422 control | 130.753 | 40 |
GSM687673 | Patient 424 control | 267.123 | 52 |
GSM687678 | Patient 425 control | 278.097 | 53 |
GSM687683 | Patient 427 control | 201.509 | 46 |
GSM687688 | Patient 428 control | 339.513 | 58 |
GSM687695 | Patient 441 control | 396.573 | 56 |
GSM687699 | Patient 443 control | 351.514 | 56 |
GSM687704 | Patient 444 control | 134.669 | 40 |
GSM687707 | Patient 448 control | 296.547 | 53 |
GSM687712 | Patient 449 control | 271.433 | 53 |
GSM687719 | Patient 450 control | 363.203 | 57 |
GSM687724 | Patient 451 control | 307.451 | 55 |
GSM687728 | Patient 452 control | 200.548 | 47 |
GSM687646 | Patient 401 treated 24h | 114.018 | 37 |
GSM687649 | Patient 402 treated 24h | 197.731 | 49 |
GSM687665 | Patient 411 treated 24h | 354.628 | 57 |
GSM687651 | Patient 402 treated 4 weeks | 216.558 | 49 |
GSM687667 | Patient 411 treated 4 weeks | 174.455 | 45 |
GSM687670 | Patient 422 treated 24h | 260.628 | 52 |
GSM687671 | Patient 422 treated 4 weeks | 342.091 | 58 |
GSM687654 | Patient 403 treated 24h | 208.89 | 51 |
GSM687675 | Patient 424 treated 24h | 338.349 | 56 |
GSM687685 | Patient 427 treated 24h | 304.771 | 55 |
GSM687656 | Patient 403 treated 4 weeks | 196.049 | 50 |
GSM687677 | Patient 424 treated 4 weeks | 297.073 | 55 |
GSM687687 | Patient 427 treated 4 weeks | 219.158 | 51 |
GSM687692 | Patient 428 treated 4h | 296.446 | 55 |
GSM687716 | Patient 449 treated 4h | 57.9283 | 25 |
GSM687722 | Patient 450 treated 4h | 489.089 | 62 |
GSM687680 | Patient 425 treated 24h | 278.258 | 54 |
GSM687690 | Patient 428 treated 24h | 399.872 | 61 |
GSM687700 | Patient 443 treated 24h | 677.844 | 66 |
GSM687705 | Patient 444 treated 24h | 208.578 | 51 |
GSM687714 | Patient 449 treated 24h | 271.161 | 55 |
GSM687721 | Patient 450 treated 24h | 326.906 | 54 |
GSM687682 | Patient 425 treated 4 weeks | 311.798 | 57 |
GSM687694 | Patient 428 treated 4 weeks | 208.785 | 50 |
GSM687702 | Patient 443 treated 4 weeks | 144.354 | 39 |
GSM687718 | Patient 449 treated 4 weeks | 244.803 | 52 |
GSM687723 | Patient 450 treated 4 weeks | 341.295 | 57 |
GSM687661 | Patient 404 treated 4h | 203.89 | 47 |
GSM687710 | Patient 448 treated 4h | 280.787 | 55 |
GSM687726 | Patient 451 treated 4h | 102.974 | 32 |
GSM687730 | Patient 452 treated 4h | 725.468 | 66 |
GSM687660 | Patient 404 treated 24h | 186.287 | 42 |
GSM687697 | Patient 441 treated 24h | 524.566 | 63 |
GSM687709 | Patient 448 treated 24h | 50.8265 | 22 |
GSM687725 | Patient 451 treated 24h | 233.143 | 48 |
GSM687729 | Patient 452 treated 24h | 492.764 | 63 |
GSM687727 | Patient 451 treated 4 weeks | 232.036 | 48 |
GSM687731 | Patient 452 treated 4 weeks | 331.133 | 56 |